“…The median V-rAG was found 66.7% (in situ) and 60.0% (extracted) between baseline and 1 year, and 57.1% in the in situ-group between baseline and the follow-up after up to 26 years.4 | D ISCUSS I ONThere are only very few studies reporting on long-term outcomes after regenerative periodontal therapies, as it was recently concluded byWu et al (2017) in their systematic review. With regard to GTR (or combined GTR/graft therapy) in intra-bony defects, there are only five studies with follow-up periods of 10 years (Nickles, Ratka-Krüger, Neukranz, Raetzke, & Eickholz, 2009; Nygaard-Østby, Bakke, Nesdal, Susin, & Wikesjö, 2010; Pretzl, Kim, Holle,& Eickholz, 2008;Pretzl et al, 2009;Sculean et al, 2008), one study with 13-year follow-up evaluating additional application of autogenous platelet concentrate(Cieplik et al, 2018) and two studies with follow-up periods of 20 years(Cortellini et al, 2017;Petsos et al, 2019). These latter two studies are prospective clinical studies comparing GTR therapy and open flap debridement (OFD) but comprise only 41 defects (in 41 patients; parallel design;Cortellini et al, 2017) or 38 defects (in 12 patients; split-mouth design;Petsos et al, 2019), respectively.…”